WANG Jun, GONG Fan, LI Tingting. Effect of modified Xinglou Chengqi Decoction on oxidative stress reactions in patients with acute cerebral infarction differentiated as phlegm-heat and sthenic-fu syndrome after intravenous thrombolysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 36-39. DOI: 10.7619/jcmp.202003011
Citation: WANG Jun, GONG Fan, LI Tingting. Effect of modified Xinglou Chengqi Decoction on oxidative stress reactions in patients with acute cerebral infarction differentiated as phlegm-heat and sthenic-fu syndrome after intravenous thrombolysis[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 36-39. DOI: 10.7619/jcmp.202003011

Effect of modified Xinglou Chengqi Decoction on oxidative stress reactions in patients with acute cerebral infarction differentiated as phlegm-heat and sthenic-fu syndrome after intravenous thrombolysis

More Information
  • Received Date: November 14, 2019
  • Objective To investigate the effect of modified Xinglou Chengqi Decoction on oxidative stress reactions in patients with acute cerebral infarction differentiated as phlegm-heat and sthenic-fu syndrome after intravenous thrombolysis. Methods A total of 80 patients with acute cerebral infarction differentiated as phlegm-heat and sthenic-fu syndrome who admitted in our hospital were selected, and were divided into control group(n=40)and research group(n=40)according to random number table method. Control group was given routine western medicine after intravenous thrombolysis, and research group was treated with modified Xinglou Chengqi Decoction on thrombolysis day based on the control group. The clinical efficacy of two groups was analyzed. The oxidative stress reactions and inflammatory factors before and after treatment were observed. Results The total effective rate of research group was significantly higher than that of control group(P < 0.05). After treatment, the levels of malondialdehyde(MDA), interleukin-1β(IL-1β), tumor necrosis factor-α(TNF-α)in research group were lower, and the superoxide dismutase(SOD)was higher than that of control group(P < 0.05). Conclusion Modified Xinglou Chengqi Decoction in treatment of phlegm-heat and sthenia-fu syndrome of acute cerebral infarction after intravenous thrombolysis is effective, it can improve oxidative stress indexes and levels of inflammatory factors, and promote nerve restoration.
  • 林玲, 刘珊珊, 马洪歌. 星蒌承气汤作用机制研究进展[J]. 世界最新医学信息文摘, 2019, 19(4): 53-54.
    吴平. 脑梗死的临床治疗研究进展[J]. 中国保健营养, 2019, 29(22): 37-38.
    王著敏, 王峰, 孙学平, 等. 消栓肠溶胶囊对缺血性中风气虚血瘀证患者血液流变学及凝血功能的影响[J]. 中国实验剂学杂志, 2015, 21(17): 190-193.
    张秋文, 文国安, 刘凤英. 急性脑梗死中医证型和同型半胱氨酸的关联性分析[J]. 现代诊断与治疗, 2018, 29(11): 1788-1789.
    毛文晴, 严锋. 急性脑梗死中医证候特点分析[J]. 中西医结合心脑血管病杂志, 2018, 16(17): 2554-2555.
    中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊治指南2010[J]. 中华医学信息导报, 2010, 25(14): 16-19.
    国家中医药管理局脑病急症协作组. 中风病诊断与疗效评定标准(试行)[J]. 中北京中医药大学学报, 1996, 19(1): 55-56.
    郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002: 77-85.
    郭笑冬. “脑腑同治”针药并用治疗方案对痰热腑实型缺血性中风急性期患者的影响[J]. 医学理论与实践, 2017, 30(2): 203-204.
    全国第四届脑血管病学术会议组. 脑卒中患者临床神经功能缺损程度评分标准(1995年)[J]. 中华神经科杂志, 1996, 29(6): 381-383.
    陈安强, 尤丛笑, 付桂丽, 等. 动脉内溶栓治疗急性脑血栓形成的初步体会[J]. 贵州医药, 2006, 30(6): 554-556.
    刘晓彤, 冯磊. 星蒌承气汤治疗痰热腑实型中风急性期临床疗效观察[J]. 世界中西医结合杂志, 2019, 14(4): 537-539.
    于海燕, 徐凤超, 朱薇, 等. 针刺联合星蒌承气汤对脑卒中大鼠血液流变学的影响[J]. 中国中医急症, 2016, 25(5): 849-851.
    苏晓丽. 循证护理联合丁苯酞及依达拉奉对急性脑梗死患者炎性因子和氧化应激的影响[J]. 河北医药, 2019, 41(12): 1907-1910

    , 1914.
    李秀云, 彭俏菁, 程巍, 等. 冰帽亚低温护理在急性脑梗塞溶栓后的应用及对神经功能、并发症和生活质量的影响[J]. 现代医院, 2018, 18(7): 1082-1084.

Catalog

    Article views (361) PDF downloads (3) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return